Cite
HARVARD Citation
Colombel, J. et al. (n.d.). P053 TARGETED RELEASE ORAL CYCLOSPORINE FORMULATION AS A POTENTIAL NEW THERAPY FOR ULCERATIVE COLITIS. Inflammatory bowel diseases. p. S26. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Colombel, J. et al. (n.d.). P053 TARGETED RELEASE ORAL CYCLOSPORINE FORMULATION AS A POTENTIAL NEW THERAPY FOR ULCERATIVE COLITIS. Inflammatory bowel diseases. p. S26. [Online].